tiprankstipranks
Trending News
More News >
H&R GmbH & Co. KGaA (DE:2HRA)
XETRA:2HRA

H&R GmbH & Co. KGaA (2HRA) AI Stock Analysis

Compare
5 Followers

Top Page

DE:2HRA

H&R GmbH & Co. KGaA

(XETRA:2HRA)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
€4.50
▲(5.88% Upside)
The overall stock score of 50 reflects significant challenges in financial performance and bearish technical indicators. The company's high P/E ratio suggests overvaluation, while the dividend yield offers limited compensation. Improving operational efficiency and profitability is crucial for enhancing future prospects.
Positive Factors
Business Model Strength
H&R's diverse product offerings across multiple industries provide a stable revenue base and reduce dependence on any single market, enhancing resilience.
Sustainability Focus
H&R's focus on sustainable products aligns with growing industry trends towards eco-friendly solutions, potentially expanding its customer base and market share.
Stable Balance Sheet
A stable balance sheet with manageable leverage provides financial flexibility, supporting long-term strategic investments and growth opportunities.
Negative Factors
Declining Revenue
Declining revenue indicates potential market challenges and competitive pressures, which could impact long-term growth and profitability.
Weak Cash Flow Generation
Weak cash flow generation limits the company's ability to invest in growth initiatives and may strain financial resources over time.
Low Profitability
Low profitability margins suggest operational inefficiencies and could hinder the company's ability to generate returns for shareholders in the long term.

H&R GmbH & Co. KGaA (2HRA) vs. iShares MSCI Germany ETF (EWG)

H&R GmbH & Co. KGaA Business Overview & Revenue Model

Company DescriptionH&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts for medical technology, automotive, and other industries. The company also provides petroleum jellies, motor oils, process oils, cable filling compounds, ozone protection waxes, cosmetic and pharmaceutical raw materials, mineral oils, and construction insulation materials. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany. H&R GmbH & Co. KGaA is a subsidiary of H&R Komplementär GmbH.
How the Company Makes MoneyH&R GmbH & Co. KGaA generates revenue through the sale of its wax products and specialty chemical solutions to various industries. The company's revenue model is primarily based on direct sales to B2B clients, leveraging long-term contracts and partnerships with major corporations in sectors such as cosmetics and packaging. Key revenue streams include the production and distribution of paraffin waxes, microcrystalline waxes, and other customized products tailored to specific industrial applications. Additionally, H&R benefits from strategic partnerships with suppliers and distributors, which enhance its market reach and operational efficiency. The company's commitment to sustainability also attracts clients looking for eco-friendly alternatives, potentially expanding its customer base and contributing to increased sales.

H&R GmbH & Co. KGaA Financial Statement Overview

Summary
H&R GmbH & Co. KGaA faces a challenging financial environment with declining revenues and profitability. While the balance sheet remains stable with manageable leverage, the company struggles with cash flow generation. Improving operational efficiency and profitability will be crucial for future growth and stability.
Income Statement
55
Neutral
The company shows a mixed performance in its income statement. The TTM gross profit margin stands at 24.38%, which is relatively healthy, but the net profit margin is quite low at 0.62%, indicating limited profitability. Revenue has declined by 2.09% in the TTM, reflecting a challenging market environment. EBIT and EBITDA margins are modest, suggesting operational efficiency challenges.
Balance Sheet
60
Neutral
The balance sheet reveals a moderate debt-to-equity ratio of 0.38 in the TTM, indicating a manageable level of leverage. Return on equity is low at 1.93%, suggesting limited returns for shareholders. The equity ratio is stable, showing a solid capital structure, but the company needs to improve its profitability to enhance shareholder value.
Cash Flow
50
Neutral
The cash flow statement highlights significant challenges, with a sharp decline in free cash flow growth by 84.48% in the TTM. The operating cash flow to net income ratio is 0.31, indicating that cash generation is not robust relative to net income. The free cash flow to net income ratio is 0.42, showing some ability to generate cash, but overall cash flow performance is weak.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.29B1.34B1.35B1.58B1.19B873.03M
Gross Profit273.20M121.06M115.78M155.57M143.55M61.56M
EBITDA86.32M91.69M88.33M123.76M131.35M48.42M
Net Income3.94M10.62M10.56M42.71M50.18M-9.02M
Balance Sheet
Total Assets983.64M1.01B903.24M962.07M874.38M745.72M
Cash, Cash Equivalents and Short-Term Investments78.69M64.01M69.44M55.89M48.92M55.03M
Total Debt160.91M194.60M202.61M244.24M196.28M177.52M
Total Liabilities531.54M546.26M445.62M490.91M465.90M398.83M
Stockholders Equity412.92M426.86M413.02M423.64M362.60M307.58M
Cash Flow
Free Cash Flow5.77M15.23M61.42M-32.04M-11.59M21.90M
Operating Cash Flow65.37M70.24M119.07M37.98M37.42M60.15M
Investing Cash Flow-58.38M-54.45M-56.26M-72.46M-48.56M-38.11M
Financing Cash Flow-16.77M-25.80M-46.94M41.51M2.48M-57.66M

H&R GmbH & Co. KGaA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.25
Price Trends
50DMA
4.51
Negative
100DMA
4.72
Negative
200DMA
4.76
Negative
Market Momentum
MACD
-0.06
Positive
RSI
40.28
Neutral
STOCH
21.09
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:2HRA, the sentiment is Negative. The current price of 4.25 is below the 20-day moving average (MA) of 4.34, below the 50-day MA of 4.51, and below the 200-day MA of 4.76, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 40.28 is Neutral, neither overbought nor oversold. The STOCH value of 21.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:2HRA.

H&R GmbH & Co. KGaA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
€161.22M11.658.44%1.82%-26.69%-1.95%
66
Neutral
€163.13M21.002.79%0.69%-3.37%15.71%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
€41.02B150.250.71%5.16%-2.94%-45.21%
53
Neutral
€501.89M-3.05-29.56%-14.48%-340.02%
50
Neutral
€158.19M40.210.94%2.27%-3.07%-28.82%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:2HRA
H&R GmbH & Co. KGaA
4.25
0.58
15.65%
DE:AAG
Aumann AG
14.04
3.25
30.16%
DE:BAS
BASF SE
45.96
3.40
7.98%
DE:GSC1
GESCO AG
15.05
2.08
15.99%
DE:SGL
SGL Carbon
4.11
0.46
12.47%
DE:OEL
ADM Hamburg Aktiengesellschaft
232.00
37.85
19.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025